Plant lactobacillus and application thereof in fermentation of periplaneta americana

By fermenting the American cockroach powder by FT1804 in Plantella lactobacillus, the content of biologically active substances was improved, and the problem of underutilization of the medicinal value of American cockroach in the prior art was solved, thus achieving the intestinal pathogens and colon cancer cells. Effectively inhibit and reduce inflammatory factors, it has potential applications for preventing and treating colitis and colon cancer.

CN118931766APending Publication Date: 2024-11-12SICHUAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410995328.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The prior art has failed to effectively utilize microbial fermentation to increase the content of bioactive substances of American cockroaches, which limits the discovery and application of its medicinal value.

Method used

A planta plantarum FT1804 was used to ferment the American cockroach powder, which increased the content of biologically active substances, including amino acids, peptides, indoles, serotonin and purine compounds, and prepared for inhibition. Fermentation supernatant of enteric pathogens and colon cancer cells.

Benefits of technology

It significantly improves the content of bioactive substances in the American cockroach powder, enhances the inhibitory ability of enteric pathogens and the growth inhibitory effect of colon cancer cells, reduces the level of inflammatory factors, and has potential applications in preventing and treating colitis and colon cancer. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931766A_ABST
    Figure CN118931766A_ABST
Patent Text Reader

Abstract

The invention discloses a plant lactobacillus and application thereof in periplaneta americana fermentation, the strain has good endurance capacity to artificial stomach and intestinal juice, and has strong inhibition capacity to escherichia coli, pseudomonas aeruginosa, staphylococcus aureus, salmonella typhimurium, salmonella paratyphi B, shigella dysenteriae and the like. When the strain is used for fermenting periplaneta americana powder, the content of amino acids and bioactive substances such as peptides, indoles, serotonins and purines in fermentation supernatant can be greatly increased, and the fermentation supernatant has relatively strong growth inhibition capability and cell apoptosis promotion capability on human colon cancer cells and has an obvious effect on DSS-induced mouse colitis; the inflammatory factor level is obviously reduced. The strain opens up a new way for further development and utilization of the traditional Chinese medicinal material periplaneta americana.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms, and in particular relates to a plant lactobacillus strain and application thereof in American cockroach fermentation. Background Art

[0002] Lactobacillus plantarum is widely distributed in fermented animal and plant products containing carbohydrates, such as dairy products, meat products, beer, wine, fruit juice, malt juice, fermented dough, etc. It is also distributed in the intestines of humans and animals. It plays an important role in maintaining the microecological balance of the digestive tract and has been widely used in food preservation, fermentation and other functional food fields. As a traditional Chinese medicinal material, American cockroach has multiple medicinal effects such as clearing away heat and detoxification, promoting diuresis and reducing swelling, dispersing blood stasis and removing accumulation, detoxification and diuresis, etc. It has been used to make Chinese patent medicines (such as Kangfuxinye) for clinical application. Kangfuxinye is an ethanol extract of dried American cockroach bodies, and its clinical application range is limited. Whether the content of bioactive substances can be increased by microbial fermentation and new medicinal values ​​can be discovered is the key to this study. Summary of the invention

[0003] The technical problem to be solved by the present invention is: how to provide a strain of Lactobacillus plantarum and its application in the fermentation of the traditional Chinese medicine American cockroach.

[0004] The technical solution of the present invention is: a strain of Lactobacillus plantarum (Lactiplantibacillus plantarum) FT1804, which was deposited in the General Microbiology Center of China Microorganism Culture Collection Administration on May 22, 2023, with a deposit number of CGMCC NO: 27392.

[0005] Application of Lactobacillus plantarum FT1804 in the inhibition of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Salmonella paratyphi B or Shigella dysenteriae for non-disease treatment purposes.

[0006] Application of Lactobacillus plantarum FT1804 in the preparation of medicines for treating diseases caused by Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Salmonella paratyphi B or Shigella dysenteriae.

[0007] The invention discloses an application of Lactobacillus plantarum FT1804 in fermenting American cockroach powder to increase the content of biologically active substances, wherein the biologically active substances are one or more of amino acids and peptides, indoles, serotonins or purine compounds.

[0008] A preparation contains American cockroach powder fermentation liquid, wherein the American cockroach powder fermentation liquid is obtained by fermenting American cockroach powder with Lactobacillus plantarum FT1804 as claimed in claim 1. Furthermore, the fermentation method is: American cockroach powder and oligofructose are prepared into a culture medium with water, after sterilization and cooling, inoculated with Lactobacillus plantarum FT1804, and cultured at 37°C for 96 hours.

[0009] The use of the above-mentioned preparation in the preparation of medicine for preventing or treating animal colitis.

[0010] The use of the above-mentioned preparation in the preparation of drugs for inhibiting colon cancer.

[0011] Compared with the prior art, the beneficial effects produced by the present invention are:

[0012] 1. The plant lactobacillus FT1804 provided by the present invention has a strong antibacterial ability against common intestinal pathogenic bacteria such as Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Salmonella paratyphi B and Shigella dysenteriae.

[0013] 2. Use of the plant lactobacillus FT1804 provided by the present invention in fermenting American cockroach powder to increase the content of bioactive substances, wherein the bioactive substances are one or more of amino acids and peptides, indoles, serotonin or purine compounds.

[0014] 3. The fermentation supernatant of American cockroach powder fermented by Lactobacillus plantarum FT1804 provided by the present invention has strong growth inhibition ability and cell apoptosis promoting ability on human colon cancer cells.

[0015] 4. The fermentation supernatant of American cockroach powder fermented by Lactobacillus plantarum FT1804 provided by the present invention has obvious effects on DSS-induced colitis in mice, and the level of inflammatory factors is significantly reduced.

[0016] Collection Information

[0017] Lactiplantibacillus plantarum FT1804 was deposited on May 22, 2023 at the General Microbiology Center of China Culture Collection Administration, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences, with the deposit number CGMCC NO: 27392. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 It is a phylogenetic relationship diagram of Lactobacillus plantarum FT1804 and other strains of the present invention;

[0019] Figure 2It is a volcano diagram of differential metabolites of American cockroach powder fermented by Lactobacillus plantarum FT1804 of the present invention;

[0020] Figure 3 The present invention shows that the fermentation supernatant of Lactobacillus plantarum FT1804 can inhibit the growth of human colon cancer cells;

[0021] Figure 4 The effect of the fermentation supernatant of Lactobacillus plantarum FT1804 of the present invention on the expression of reactive oxygen species in human colon cancer cells;

[0022] Figure 5 The invention discloses the apoptosis-promoting effect of the fermentation supernatant of Lactobacillus plantarum FT1804 on human colon cancer cells. DETAILED DESCRIPTION

[0023] The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are purchased from commercial channels unless otherwise specified.

[0024] Example 1 Isolation, screening and molecular biological identification of Lactobacillus plantarum FT1804:

[0025] 1. Material Preparation

[0026] The strain was sourced from the feces of healthy infants;

[0027] The 16S rDNA universal primers 27F and 1492R were synthesized by Sangon Biotech (Shanghai) Co., Ltd. The sequences are as follows:

[0028] 27F: 5-AGAGTTTGATCMTGGCTCAG-3,

[0029] 1492R:5-GGTTACCTTGTTACGACTT-3

[0030] The formula of MRS broth medium (per liter): 10.0 g of casein digest, 10.0 g of beef extract powder, 4.0 g of yeast extract powder, 2.0 g of triammonium citrate, 5.0 g of sodium acetate, 0.2 g of magnesium sulfate, 0.05 g of manganese sulfate, 2.0 g of dipotassium hydrogen phosphate, 20.0 g of glucose, Tween-80, and the final pH is about 5.7.

[0031] The formula of MRS agar medium (per liter): peptone 10.0g, beef extract powder 5.0g, yeast extract powder 4.0g, glucose 20.0g, Tween 80 1.0mL, dipotassium hydrogen phosphate 2.0g, sodium acetate 5.0g, triammonium citrate 2.0g, magnesium sulfate 0.2g, manganese sulfate 0.05g, agar 15.0g, the final pH is about 6.2.

[0032] 2. Specific methods

[0033] Take 2g of fecal sample in 20mL MRS broth, shake thoroughly and mix, and place in a 37℃ constant temperature shaker for 24h. Use 10-fold gradient dilution, spread and inoculate on MRS agar medium, pick a single colony after culturing at 37℃ for 24h, and purify the single colony three times in a row. Inoculate the purified strain into 600μL MRS broth medium, culture at 37℃ shaker for 18h, add 400μL 50% (V / V) sterile glycerol, and freeze in a -80℃ ultra-low temperature refrigerator for later use. The purified strains were propagated in MRS broth, and the strain DNA was extracted using the Tiangen Bacteria Genomic DNA Extraction Kit. 16S rRNA amplification was completed using colony PCR technology, and the PCR product sequencing was completed by Sangon Biotechnology (Shanghai) Co., Ltd. to obtain a target gene sequence consisting of 1139 base pairs (bp) (SEQ ID No. 1). The sequence was compared with BLAST in NCBI, and one of the strains had a similarity of 99.38% with the standard strain Lactobacillus plantarum strain TMPC 2071G. The strain was preliminarily identified as Lactobacillus plantarum and named FT1804. The phylogenetic relationship between the strain and other strains is shown in the attached Figure 1 . The kit method was used to perform Gram staining on Lactobacillus plantarum FT1804, and the bacterial morphology after staining was observed and recorded under a microscope. Lactobacillus plantarum FT1804 grew well on MRS agar medium. The colony morphology was milky white, with round protrusions, flat edges and smooth surfaces. Microscopic examination showed that the bacteria were rod-shaped and purple, which was consistent with the characteristics of Lactobacillus plantarum. The strain was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration on May 22, 2023, at the Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, with the deposit number CGMCC NO: 27392.

[0034] Example 2 Probiotic properties of Lactobacillus plantarum FT1804 strain

[0035] 2.1 Adhesion to human colon cancer cells

[0036] After the frozen strain of Lactobacillus plantarum FT1804 was revived and inoculated into MRS broth medium, the culture was cultured at 37°C for 24 hours. After the culture was completed, the culture was centrifuged at -4°C and 5000r / min for 10 minutes, and washed several times with sterile PBS buffer. The concentration of the bacterial suspension was adjusted to 1×10 6CFU / mL and set aside. Resuscitate human colon cancer cells HT-29, inoculate them into six-well cell culture dishes, add DMEM complete medium and culture at 37°C, 5% CO2, and change the culture medium every two days. When the cell adhesion state reaches 80%, use 0.25% trypsin-EDTA for digestion and subculture. After the culture is completed, count them with a cell blood cell counting plate and adjust the cell concentration to 5×10 6 / mL. Add 1mL of cell suspension to one of the culture wells of a six-well cell culture dish and place it in an incubator for culture. When the cells in the culture plate grow to a monolayer, discard the DMEM culture medium and rinse each well 3 times with sterile PBS. Add 1mL of the prepared bacterial suspension to the cell well, shake the cell culture plate slightly, and aspirate a small amount of bacterial liquid in the well for plate counting. The result is used as the initial number of viable bacteria in the bacterial suspension. Incubate the cell plate at 37℃ for 2h, discard the culture medium and wash 3 times with sterile PBS buffer. Use 0.7mL of 0.25% trypsin-EDTA to digest the cells for 10min. After the cells are completely detached, add 0.3mL of DMEM culture medium to terminate the digestion. Collect the culture medium after the adhesion experiment for plate counting. The result is used as the number of adhered viable bacteria. Adhesion rate (%) = number of lactic acid bacteria at the end of the period / initial number of lactic acid bacteria inoculated × 100%

[0037] The results are shown in Table 1. The results show that the adhesion rate of Lactobacillus plantarum FT1804 to human colon cancer cell HCT116 is 56.63%.

[0038] Table 1 Adhesion rate of Lactobacillus plantarum FT1804 to human colon cancer cell HCT116 (%)

[0039] strain Repeat 1 Repeat 2 Repeat 3 Mean FT1804 59.31 62.59 47.97 56.63±6.26

[0040] 2.2 Tolerance of Lactobacillus plantarum FT1804 to simulated gastric and intestinal fluids

[0041] Simulated gastric juice and intestinal juice were purchased from Shanghai Yuanye Biotechnology Co., Ltd. The artificial gastric juice simulation liquid contains dilute hydrochloric acid, pepsin and sodium chloride, with a final pH of 2.5; the artificial intestinal juice simulation liquid contains potassium dihydrogen phosphate and trypsin, with a final pH of 6.8. The strain Lactobacillus plantarum FT1804 to be tested was revived and activated for 3 generations on MRS agar plates, and the initial concentration of the bacterial solution was adjusted to 1×10 6CFU / mL. 1mL of the test strain Lactobacillus plantarum FT1804 was inoculated into simulated gastric fluid and cultured at 37°C for 3h. After the culture was completed, 20μL of the bacterial solution was spread on the MRS agar plate medium, set up 3 replicates, and cultured at 37°C for 24h. After the culture, observe whether there was colony growth on the surface of the MRS plate. Similarly, 1mL of the test strain Lactobacillus plantarum FT1804 was inoculated into simulated intestinal fluid, cultured at 37°C for 6h, then spread on the plate and cultured at 37°C for 24h to check the colony growth.

[0042] The results of the gastric simulated fluid tolerance test showed that Lactobacillus plantarum FT1804 could still grow normal colonies on MRS agar plates after being treated in simulated gastric fluid for 3 hours; the results of the intestinal simulated fluid tolerance test showed that Lactobacillus plantarum FT1804 could still grow normal colonies on MRS agar plates after being treated in simulated intestinal fluid for 6 hours, indicating that Lactobacillus plantarum FT1804 has strong acid and bile resistance.

[0043] 2.3 Antibacterial activity against common intestinal pathogens

[0044] Escherichia coli (CMCB 44102), Pseudomonas aeruginosa (CMCB 10104), Staphylococcus aureus (CMCB 50094), Salmonella typhimurium (ATCC14028), Salmonella paratyphi B (CMCB 50094) and Shigella dysenteriae (CMCB 51105) were inoculated into nutrient agar medium, revived and activated three times. An appropriate amount of tryptic soy bean liquid medium was drawn into a centrifuge tube, and the activated pathogenic bacteria were inoculated into the broth medium, and the bacterial solution concentration was adjusted to 1×10 8 CFU / mL. Take 1mL of the mixture of the above pathogenic bacteria and broth and add it to 500mL of sterilized nutrient agar medium that has not yet solidified (the temperature has been cooled to about 40°C), mix thoroughly and dispense into culture dishes at a volume of 20mL per dish. After the culture medium has cooled and solidified, use a 6mm diameter puncher to punch holes on the plate to make pathogenic bacteria agar plates. Each plate corresponds to one strain of bacteria, and three holes are set as replicates. Resuscitate and activate the strain to be tested, and adjust the concentration of the cultured bacterial solution to 1×10 8CFU / mL. Pipette 50 μL of the test bacterial solution into the wells of the pathogenic bacteria agar plate and culture at 37°C for 24 hours. After culture, use a vernier caliper to measure the diameter of the inhibition zone around the punch point and record it. Use the standard strain LGG as the control strain and perform the above experimental operations simultaneously with the test strain.

[0045] The fermentation broth had strong inhibitory activity against the growth of pathogenic bacteria such as Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Salmonella paratyphi B and Shigella dysenteriae, which was basically equivalent to the effect of the LGG standard strain (Table 2). This shows that the bacterial agent prepared by Lactobacillus plantarum FT1804 strain can be used for the prevention and control of the above pathogenic bacteria.

[0046] Table 2 Evaluation of antibacterial activity of Lactobacillus plantarum FT1804 strain (diameter: mm)

[0047]

[0048] 2.4 Antioxidant activity of Lactobacillus plantarum FT1804 fermentation broth

[0049] Antioxidants are any substances that can effectively inhibit the oxidation reaction of free radicals in low concentrations to offset the oxidative attack of free radicals on human cells. Its mechanism of action can be to act directly on free radicals, or to indirectly consume substances that easily generate free radicals to prevent further reactions. The stronger the body's antioxidant capacity, the healthier it is and the longer its life. More and more studies have shown that anti-oxidation is an important step in preventing aging, because free radicals or oxidants will decompose cells and tissues, affect metabolic functions, and cause different health problems. If excessive oxidative free radicals can be eliminated, many free radical-induced and aging-related diseases can be prevented. For example, common cancers, arteriosclerosis, diabetes, cataracts, cardiovascular disease, Alzheimer's disease, arthritis, etc., these diseases are all considered to be related to free radicals.

[0050] Preparation of fermentation broth: After the frozen strain of Lactobacillus plantarum FT1804 was revived and cultured for 24 hours, it was inoculated into MRS liquid culture medium at a 2% inoculum amount and cultured at 37°C for 24 hours. The bacterial solution was centrifuged at 4°C and 4000r / min for 15 minutes. The supernatant was filtered through a 0.22μm filter membrane to obtain the fermentation supernatant (CFS) and frozen for later use.

[0051] Reagents and instruments: Hydroxyl radical assay kit (A018-1-1), DPPH radical scavenging kit (A153-1-1) and superoxide anion radical inhibition and generation assay kit (colorimetric method A052-1-1) were all produced by Nanjing Jiancheng Bioengineering Research Institute. UV-visible spectrophotometer (UV752N model) was produced by Shanghai Youke Instrument Co., Ltd.; fermentation broth antioxidant capacity determination was completed by Chengdu Lilai Biotechnology Co., Ltd.

[0052] Hydroxyl free radical inhibition ability: Hydroxyl free radical is a kind of active oxygen with strong electron-accepting ability, that is, strong oxidizing ability. Hydroxyl free radical can kill red blood cells, degrade DNA, cell membrane and polysaccharide compounds. The measurement results are shown in Table 8, and the plant lactobacillus FT1804 fermentation liquid has a strong ability to inhibit hydroxyl free radicals, which is 5999.58±48.84U / mL.

[0053] DPPH free radical scavenging ability: DPPH, also known as 1,1-diphenyl-2-trinitrophenylhydrazine, is a very stable nitrogen-centered free radical. Since the DPPH free radical has a single electron, it has a strong absorption at 517nm, and its alcohol solution is purple. When a free radical scavenger is present, its absorption gradually disappears due to pairing with its single electron, and the lighter the color, the more DPPH scavenging ability in the sample can be quantitatively analyzed. The results of the DPPH free radical scavenging ability determination of the Lactobacillus plantarum FT1804 fermentation broth are shown in Table 3. It can be seen that the DPPH free radical scavenging ability of the Lactobacillus plantarum FT1804 fermentation broth is 176.20±1.89μgTrolox / mL, indicating that the Lactobacillus plantarum FT1804 fermentation broth has a certain scavenging ability for DPPH free radicals.

[0054] Superoxide anion resistance: Superoxide anion free radical, as a free radical produced in the metabolic process of organisms, can attack biological macromolecules, such as lipids, proteins, nucleic acids and polyunsaturated fatty acids, causing cross-chain or rupture, causing the destruction of cell structure and function, and having a close relationship with body aging and pathological changes. The superoxide anion resistance ability of plant lactobacillus FT1804 fermentation liquid is measured as shown in Table 8 below, and it can be seen that the inhibition ability of plant lactobacillus FT1804 fermentation liquid to superoxide anion free radical is 773.10±10.30 (U / L), indicating that the inhibition ability of plant lactobacillus FT1804 fermentation liquid to superoxide anion free radical is strong.

[0055] Table 3 Antioxidant capacity of Lactobacillus plantarum FT1804 fermentation broth

[0056]

[0057] Example 3 Application of Lactobacillus plantarum FT1804 strain in fermentation of American cockroach powder

[0058] 3.1 Fermentation and analytical methods

[0059] Fermentation method: 10 grams of American cockroach powder, 3 grams of oligofructose, and 100 mL of water were prepared into a culture medium. After sterilization and cooling, plant lactobacillus FT1804 was inoculated and cultured at 37°C for 96 hours. The fermentation broth was centrifuged at 4000 rpm and 4°C for 10 minutes, and the supernatant was filtered through a bacterial filter membrane and sent to the company for liquid chromatography-mass spectrometry (LC-MS) non-targeted metabolomics analysis. The experiment was set up with three replicates, and the control group without probiotics was used. The culture and analysis methods were the same as those of the treatment group.

[0060] Analytical methods: Based on high-resolution mass spectrometry (HRMS) detection technology, the high-quality mzCloud database constructed by standards is combined with the mzVault and MassList databases to match and identify molecular characteristic peaks. The raw data is preprocessed using CD3.3 data processing software. First, simple screening is performed by parameters such as retention time and mass-to-charge ratio, and the peak area is quantified at the same time. Then, the high-resolution secondary spectrum databases mzCloud and mzVault and the MassList primary database are compared (searched) to identify metabolites. Using CD3.3 data processing software, the chromatographic peaks detected in the sample are integrated, where the peak area of ​​each characteristic peak represents the relative quantitative value of a metabolite. The total peak area is used to standardize the quantitative results, and finally the quantitative results of the metabolites are obtained. The results are expressed as the multiple increase in the content of the corresponding component in the sample compared with the control.

[0061] 3.2 Analysis results

[0062] Metabolomics analysis showed that after 96 hours of fermentation of American cockroach powder with Lactobacillus plantarum FT1804, 189 compounds were detected to have significantly increased levels, 225 compounds to have significantly decreased levels, and 782 compounds to have no significant differences in levels in the positive ion mode. In the negative ion mode, 58 compounds were detected to have significantly increased levels, 247 compounds to have significantly decreased levels, and 372 compounds to have no significant differences in levels. The metabolite difference volcano plot is shown in the figure below. Figure 2 .

[0063] (1) Amino acids and peptide compounds:

[0064] Amino acids are the basic building blocks of proteins and play an important role in human health and normal functions, such as protein synthesis, physiological regulation, immune function, energy supply, and maintaining acid-base balance. The analysis results showed that after 96 hours of fermentation of American cockroach powder with Lactobacillus plantarum FT1804, the content of various amino acids and their derivatives in the supernatant increased greatly, especially succinyl-L-homoserine, pantetheine, and homocysteine, which were 35.96 times, 26.14 times, and 12.15 times that of the control, respectively. The content of other amino acids increased significantly (Table 4). As an important biochemical intermediate, succinyl-L-homoserine plays a key role in the metabolism and biosynthesis of amino acids. Pantethine is a vitamin B5 derivative with multiple biological activities. It is mainly used to improve lipid metabolism and anti-platelet aggregation. Clinical studies have shown that within a dosage range of 300 to 600 mg, it has a significant lipid-lowering effect on patients with hyperlipidemia. It can also increase the fluidity of platelet cell membranes, thereby inhibiting platelet aggregation and helping to prevent thrombosis.

[0065] The content of a polypeptide (L-Leucyl-L-Alanine) and a dipeptide (D-Ala-D-Ala) in the fermentation broth also increased significantly, 5.64 times and 5.05 times that of the control, respectively. Many active substances in the human body exist in the form of peptides. Peptides are involved in the human body's hormones, nerves, cell growth and reproduction. Their importance lies in regulating the physiological functions of various systems and cells in the body, activating relevant enzyme systems in the body, promoting the permeability of intermediate metabolic membranes, or controlling DNA transcription or affecting specific protein synthesis, ultimately producing specific physiological effects.

[0066] Table 4 Changes in the contents of amino acids and peptides after fermentation of American cockroach powder by Lactobacillus plantarum FT1804 strain

[0067]

[0068] (2) Indole compounds:

[0069] Indole and its derivatives are closely related to intestinal microbiota and human health, such as gastrointestinal motility, intestinal barrier, and neural regulation. The analysis results showed that after 96 hours of fermentation of American cockroach powder with Lactobacillus plantarum FT1804, the content of various indole derivatives in the supernatant increased significantly, especially the content of indoleacetic acid was 18.6 times that of the control. It showed significant anti-inflammatory effects in in vitro studies, inhibited LPS-induced inflammatory response, and reduced TNF-α-induced IL-8 levels. It has broad application prospects in anti-inflammatory, antiviral and immunomodulatory aspects. In addition, the content of indole-3-pyruvic acid and aminoindole increased significantly, and indole-3-pyruvic acid has potential value in anti-inflammatory and anti-anxiety drugs. Aminoindole and its derivatives are important intermediates for many drugs, such as anticancer drugs, antibacterial drugs, antidepressants, etc. (Table 5).

[0070] Table 5 Changes in indole content after fermentation of American cockroach powder by Lactobacillus plantarum FT1804 strain

[0071]

[0072] (3) Serotonin

[0073] Serotonin, also known as 5-hydroxytryptamine, is an important neurotransmitter that is mainly found in the brain and gastrointestinal tract. It has a significant regulatory effect on mood, sleep, appetite, cardiovascular health, etc. The analysis results show that after 96 hours of fermentation of American cockroach powder by Lactobacillus plantarum FT1804, the content of three serotonin substances in the supernatant increased significantly. 5-Hydroxytryptophan (5-HTP) is an amino acid substance that mainly acts as a precursor of 5-hydroxytryptamine (5-HT) in the human body. It has potential effects in increasing serotonin levels, improving mood and mental health, promoting sleep, pain relief, appetite control, and neuroprotection (Table 6).

[0074] Table 6 Changes in serotonin content after fermentation of American cockroach powder by Lactobacillus plantarum FT1804 strain

[0075]

[0076] (4) Purines

[0077] Purine and its derivatives play a variety of important roles in organisms, involving the transmission of genetic information, energy metabolism, cell signal transduction and other aspects. At the same time, purine derivatives also play an important role in drug development, providing new ways and possibilities for the treatment of various diseases. The analysis results show that after the American cockroach powder was fermented by Lactobacillus plantarum FT1804 for 96 hours, the content of various purines and their derivatives in the supernatant increased greatly, such as methylguanine and dimethyluric acid, which were 32.28 and 25.96 times that of the control, respectively. Methylguanine is a derivative of purine and plays an important role in DNA repair and epigenetic regulation. Kinetin is a non-natural cytokinin that plays a variety of important roles in biological and agricultural applications. Tenofovir is a nucleoside analogue whose mechanism of action is to inhibit viral replication by binding to the DNA polymerase of hepatitis B virus. It is mainly used to treat chronic hepatitis B and AIDS. Thioguanine, as an important anti-tumor drug, plays an important role in the treatment of leukemia and other blood diseases. Xanthine and its derivatives (such as caffeine and theophylline) have central nervous system stimulant effects (Table 7).

[0078] Table 7 Changes in the content of purine compounds after fermentation of American cockroach powder by Lactobacillus plantarum FT1804 strain

[0079]

[0080] Experimental Example 4 Growth inhibition and apoptosis-promoting ability of the supernatant of Lactobacillus plantarum FT1804 and American cockroach powder fermentation on human colon cancer cells

[0081] 4.1 Growth inhibition ability of Lactobacillus plantarum FT1804 on HT-29 cells:

[0082] Cell culture: Take out the human colon cancer cell HT-29 culture dish, remove the culture medium, add 1ml PBS to wash, add 1ml trypsin after removal, mix gently, digest for 2min, until the cells are observed to be round under an optical microscope, then remove the trypsin, add 1ml culture medium, blow with a pipette to suspend the cells, and transfer to a 1.5ml EP tube. Centrifuge at 1200rpm / min for 3min and remove the supernatant, add 300μL culture medium and mix by blowing, pipette 150μL into the culture dish containing 4ml culture medium, mix gently, place in a CO2 incubator and continue to culture. After 48h, follow the cell passage method until centrifugation. Discard the supernatant, mix the cells with 1ml culture medium, then count with a hemocytometer, and dilute the cell suspension to 3×10 4CFU / ml. Add 100 μL of cell suspension to each well of the 96-well cell plate, place in a CO2 incubator for culture, and remove the culture medium after the cells adhere to the wall and grow well.

[0083] Cytotoxicity test: Take the fermentation supernatant of American cockroach powder of Lactobacillus plantarum FT1804 strain described in Example 3, add it to serum-free cell culture medium at 4% (v / v), add 100 μL to each cell culture well, and culture for 24h, 48h and 72h respectively. The serum-free cell culture medium without fermentation supernatant is used as the control, and 3 repetitions are set.

[0084] CCK-8 detection of cell proliferation: aspirate the culture medium of the cytotoxicity experiment, add 100 μl CCK-8 solution to each well, continue to culture in the incubator for 1.5 hours, and measure OD with an enzyme marker 562 The values ​​represent the cell growth activity.

[0085] The results showed that the fermentation supernatant of Lactobacillus plantarum FT1804 strain had a good growth inhibitory effect on human colon cancer HT-29 cells. After treatment for 24h, 48h or 72h, the growth inhibition rates were 42.90%, 12.01% and 18.59%, respectively, with the most prominent performance in the first 24 hours.

[0086] Table 8 Growth inhibition of HT-29 cells by supernatant of Lactobacillus plantarum FT1804 strain American cockroach powder fermentation (%)

[0087]

[0088] 4.2 Effect of Lactobacillus plantarum FT1804 fermentation supernatant on HT-29 cell colony formation ability:

[0089] Resuscitated colon cancer cell HT-29 cells were plated at a density of 2000 cells per well in a 6-well plate and cultured for 3 weeks in a serum-free medium containing 1% American cockroach powder fermentation supernatant. Fresh medium was replaced every two days to ensure good cell growth. After visible clones were formed in the cell culture plate, the medium was discarded, washed with PBS and fixed with methanol for 30min-2h. 1% crystal violet was added for 30min, the residual crystal violet dye was washed off, and the culture plate was dried. Serum-free medium without American cockroach powder fermentation supernatant was used as a negative control, and the experiment was repeated 3 times.

[0090] The results are shown in Table 9. The growth density of HT-29 cells in the group treated with the supernatant of Lactobacillus plantarum FT1804 fermentation was significantly lower than that in the control group ( Figure 3), the number of cell colonies was only 33.87% of that in the control group, and the cell density was reduced by 66.13%, indicating that its fermentation broth has a significant growth inhibitory effect on human colon cancer cells.

[0091] Table 9 Inhibitory effect of the supernatant of Lactobacillus plantarum FT1804 American cockroach powder fermentation on HT-29 cell colony formation

[0092]

[0093] 4.3 Effect of the fermentation supernatant of Lactobacillus plantarum FT1804 and American cockroach powder on the level of reactive oxygen species (ROS) in HT-29 cells:

[0094] Cell collection: After incubating the supernatant of Lactobacillus plantarum FT1804 American cockroach powder with adherent cultured HT-29 cells for 48 hours, the fermentation supernatant was aspirated and repeatedly blown with serum-free culture medium. The bottom of the well plate (bottom of the bottle) turned from translucent (cell monolayer connected into a sheet) to transparent by naked eye observation, and almost all the cell layer was blown into the culture medium. All the cell suspensions were collected in a 1.5 ml centrifuge tube. Washed twice with serum-free culture medium, 1000r / min, centrifuged for 5min, aspirated the supernatant, and kept the cell pellet for determination.

[0095] Loading probe: Dilute DCFH-DA with serum-free culture medium at 1:1000 to a final concentration of 10μmol / L. After collecting cells, suspend them in the diluted DCFH-DA at a cell concentration of 1 million to 20 million / mL and incubate in a 37°C cell culture incubator for 20 minutes. Invert and mix every 3-5 minutes to allow the probe and cells to fully contact. Wash the cells 3 times with serum-free cell culture medium to fully remove the DCFH-DA that has not entered the cells.

[0096] Detection: Use an inverted fluorescence microscope to detect the intensity of fluorescence at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. Use the unfermented supernatant as a negative control, and set up 3 replicates of the experiment.

[0097] The level of reactive oxygen species (ROS) reflects the state of cellular metabolic products. Under normal circumstances, the generation and removal of ROS are in a dynamic balance. If the level of ROS exceeds the normal range, it may cause oxidative damage or cell death. Figure 4 The fluorescence intensity of HT-29 cells treated with Lactobacillus plantarum FT1804 fermentation supernatant was significantly higher than that of the control group, the number of fluorescently labeled cells was also greater, and the ROS expression level was significantly higher than that of the control group. This indicates that Lactobacillus plantarum FT1804 American cockroach powder fermentation supernatant has a promoting effect on the expression of reactive oxygen species in colon cancer cells (Table 10).

[0098] Table 10 Effect of fermentation supernatant of Lactobacillus plantarum FT1804 strain on reactive oxygen species expression in human colon cancer cells

[0099]

[0100] 4.4 Pro-apoptotic ability of Lactobacillus plantarum FT1804 strain on human colon cancer HT-29 cells

[0101] One-step TUNEL cell apoptosis detection was used. After incubating the supernatant of Lactobacillus plantarum FT1804 American cockroach powder with adherent cultured HT-29 cells for 48 hours, the fermentation supernatant was aspirated and washed once with PBS. The cells were fixed with 4% paraformaldehyde for 30 minutes and washed again with PBS. PBS containing 0.3% Triton X-100 was added and incubated at room temperature for 5 minutes. After preparing the TUNEL detection solution, it was fully mixed, 50μL TUNEL detection solution was added to the HT-29 cells, and incubated at 37℃ in the dark for 60min. Washed 3 times with PBS, and then sealed with anti-fluorescence quenching sealing solution and observed under an inverted fluorescence microscope, with an excitation wavelength of 550nm and an emission wavelength of 570nm. The non-fermented supernatant was used as a negative control, and the experiment was repeated 3 times.

[0102] After being treated with the supernatant of Lactobacillus plantarum FT1804 fermentation, the number of apoptotic HT-29 cells increased significantly, and the fluorescence intensity was significantly higher than that of the control group (Table 11, Figure 5 ), indicating that the fermentation supernatant of Lactobacillus plantarum FT1804 and American cockroach has a significant effect on promoting the apoptosis of HT-29 cells.

[0103] Table 11 Pro-apoptotic activity of fermentation supernatant of Lactobacillus plantarum FT1804 strain on human colon cancer cells

[0104]

[0105] Experimental Example 5 Effect of Lactobacillus plantarum FT1804 American cockroach fermentation liquid on colitis in mice

[0106] Dextran sulfate sodium salt (DSS) was used to prepare a 4% (w / v) aqueous solution. The sterile supernatant of American cockroach powder fermented by plant lactobacillus FT1804 strain for 96 hours was used for gavage. 27 4-week-old SPF male Kunming mice (Chengdu Dashuo Experimental Animal Co., Ltd.) were randomly divided into 9 cages, 3 mice in each cage, and after adaptive feeding, they were randomly divided into 3 groups, 3 cages in each group, including a blank control group (CK), a DSS model group, and a fermentation supernatant treatment group. The experimental treatments are shown in Table 8.

[0107] Table 12 Experimental grouping of the effect of the fermentation supernatant of American cockroach powder on colitis in mice

[0108]

[0109]

[0110] Serum inflammatory factor detection: At the end of the experiment, three mice were randomly killed in each group, and blood was collected from the eye sockets. The blood was centrifuged at 3000 r / min for 15 min to obtain serum. The inflammatory factors (IL-1β, IL-6, IL-8, IL-10 and TNF-α) in the serum were determined using ELISA kits according to the instructions of the kit.

[0111] The results of animal experiments showed that the mice in the DSS-treated group showed obvious symptoms of colitis, such as mental depression, decreased activity, loose stools with blood, weight loss, shortened colorectal length, etc., while the symptoms of the animals gavaged with the fermentation supernatant of American cockroach powder were significantly alleviated (Table 9).

[0112] Table 13 Effects of the supernatant of American cockroach powder fermentation on organ indexes of colitis mice

[0113]

[0114] The determination of five serum inflammatory factors (IL-1β, IL-6, IL-8, IL-10, and TNF-α) showed that the levels of serum inflammatory factors in mice in the DSS model group were significantly increased, while the levels of serum inflammatory factors in mice in the group treated with the fermentation supernatant of American cockroach powder were significantly lower than those in the DSS model group (Table 10), indicating that oral administration of fermentation liquid has an alleviating effect on colitis in mice.

[0115] Table 14 Effects of the supernatant of American cockroach powder fermentation on serum inflammatory factors in colitis mice

[0116]

[0117] Compared with the CK group, *p<0.05, **p<0.01; compared with the DSS group, #p<0.05, ##p<0.01.

Claims

1. A strain of Lactobacillus plantarum FT1804, deposited in the General Microbiological Center of China Microbiological Culture Collection Administration, with the deposit number of CGMCC NO:27392.

2. A biological preparation containing the plant lactobacillus (Lactiplantibacillus plantarum) FT1804 or its fermentation liquid according to claim 1.

3. Use of the plant lactobacillus FT1804 described in claim 1 in inhibiting Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Salmonella paratyphi B or Shigella dysenteriae for non-disease treatment purposes.

4. Use of the plant lactobacillus FT1804 according to claim 1 in the preparation of a medicament for treating diseases caused by Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Salmonella paratyphi B or Shigella dysenteriae.

5. Use of the plant lactobacillus (Lactiplantibacillus plantarum) FT1804 according to claim 1 in fermenting American cockroach powder to increase the content of biologically active substances, wherein the biologically active substances are one or more of amino acids and peptides, indoles, serotonins or purine compounds.

6. A preparation, characterized in that The invention contains American cockroach powder fermentation liquid, wherein the American cockroach powder fermentation liquid is obtained by fermenting American cockroach powder with the plant lactobacillus (Lactiplantibacillus plantarum) FT1804 described in claim 1.

7. The preparation according to claim 6, characterized in that The fermentation method comprises the following steps: preparing a culture medium with American cockroach powder and oligofructose with water, sterilizing and cooling the medium, inoculating plant lactobacillus FT1804, and culturing the medium at 37°C for 96 hours.

8. Use of the preparation according to claim 6 in the preparation of a medicament for preventing or treating colitis in animals.

9. Use of the preparation according to claim 6 in the preparation of a drug for inhibiting colon cancer.